 |
|
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
Clin Mol Hepatol. 2024;30(4):735-755. Published online 2024 May 29 DOI: https://doi.org/10.3350/cmh.2024.0058
|
|
Citations to this article as recorded by
 Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Antonio Bertoletti, Anthony T Tan
Clinical and Molecular Hepatology.2025; 31(1): e113. CrossRef Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer
Clinical and Molecular Hepatology.2025; 31(1): e44. CrossRef T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, Safia Obaidur Rab, Suhas Ballal, Abhayveer Singh, Anima Nanda, Subhashree Ray, Ahmed Hjazi, Hatif Abdulrazaq Yasin
Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef Hepatitis B: Neue therapeutische Ansätze für eine funktionelle Heilung
Markus Cornberg, Ulrike Protzer
Deutsches Ärzteblatt Online.2025;[Epub] CrossRef Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
Tao Zhang, Cong Ren, Zhanyu Yang, Ning Zhang, Haowen Tang
Frontiers in Immunology.2025;[Epub] CrossRef Viral oncogenesis in cancer: from mechanisms to therapeutics
Qing Xiao, Yi Liu, Tingting Li, Chaoyu Wang, Sanxiu He, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yongzhong Wu, Yao Liu
Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef Unlocking T‐Cell Plasticity in the Tumor Microenvironment: Implications for Cancer Progression and Therapeutic Strategies
Xiao‐Hong Ding, Xue‐Pei Li, Fenfang Chen, Han Wang, Yi‐Zhou Jiang
MedComm – Oncology.2025;[Epub] CrossRef Immunotherapy for hepatocellular carcinoma
Zhiqi Guan, Guiqi Zhu, Weiren Liu, Yinghong Shi
Clinical Cancer Bulletin.2025;[Epub] CrossRef Chimeric Antigen Receptor (CAR) T-cell Therapy: Engineering Immune Cells To Treat Liver Diseases
Elmar Jaeckel, Scott L. Friedman, Michael Hudecek, Ulrike Protzer
Journal of Hepatology.2025;[Epub] CrossRef Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma
Kyung Won Park, Tae Hoon Park, Eun Ji Jang, Pil Soo Sung
Journal of Digestive Cancer Research.2024; 12(2): 115. CrossRef Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcin
Antonio Bertoletti, Anthony T Tan
Clinical and Molecular Hepatology.2024; 30(4): 728. CrossRef
|